3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
7
Recurrence
5
Leukemia, Myeloid, Acute
5
Glioblastoma
4
Colorectal Neoplasms
3
Neoplasms, Plasma Cell
2
Melanoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Glioma
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Richter's Transformation
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Interventions
Dexamethasone
17
Melphalan
14
Bortezomib
10
Calcium Dobesilate
8
Filgrastim
6
Granulocyte Colony-Stimulating Factor
5
Cyclophosphamide
5
birtamimab
4
dexamethasone acetate
3
Whole-Body Irradiation
3
Thalidomide
3
Peripheral Blood Stem Cell Transplantation
3
Lenalidomide
3
fludarabine phosphate
2
daratumumab
2
Mycophenolic Acid
2
Etoposide
2
Doxycycline
2
Darbepoetin alfa
2
Cyclosporine
2
Busulfan
2
Blood Component Removal
2
pomalidomide
1
pegfilgrastim
1
ixazomib
1
isatuximab
1
ferrous sulfate
1
ferric gluconate
1
dexamethasone 21-phosphate
1
carfilzomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoglobulin Light-chain Amyloidosis
×
selinexor
×
Clear all
No trials found.